Since its inception if 1974, the CVD has worked nationally and internationally to prevent diseases and save lives through the development and delivery of vaccines. As an academic research center, CVD is engaged in the full range of vaccinology, including basic science research, vaccine development, pre-clinical and clinical evaluation, and post-marketing field studies.
The CVD legacy:
- Landmark and bountiful scientific publications
- Diverse portfolio of grants, contracts, and Grantees
- 94 patents issued
- 6 licensed vaccines
- Trained domestic leaders in vaccinology
- Faculty are national and international experts
- Leaders in Chile, Mali, Peru, Malawi, and Indonesia
- The CVD "brand"
After 40 plus years of success, Founder and Former Director Myron Levine, MD, DTPH passed the staff to Director Kathleen Neuzil, MD, MPH.
As the CVD grew to much more than vaccine development, the Institute for Global Health (IGH) was born in 2015. Under the Directorship of Chris Plowe, MD, MPH, the IGH includes the CVD and the Division of Malaria Research. Former CVD Director Myron M. Levine, MD, DTPH is a senior advisor to the IGH and Associate Dean for Global Health, Vaccinology, and Infectious Diseases.
The IGH is dedicated to improving global health by conducting innovative, leading research in Baltimore and around the world and developing new and improved ways to diagnose, prevent, treat, control, and eradicate diseases of global impact. Currently, these diseases include malaria, Ebola, and vaccine-preventable infectious diseases such as measles. The IGH plans to expand to relevant non-communicable diseases.